During pathological events such as myocardial infarction, ischemia–reperfusion injury, and metabolic disorders, GDF15 expression increases in multiple tissues, including the kidney [8,16], heart [17], skeletal muscles [18], and adipose tissue [19]. Here, GDF15 is linked to myocardial infarction.